Completed
Phase 3
Age: 21Years - 50Years
All Genders
ID00000248
Dose Response Trial of Pergolide for Cocaine Dependence
Led by Medical University of South Carolina · Updated on 2018-05-16
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Medical University of South Carolina
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
CONDITIONS
Brief Title
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Who Can Participate
Age: 21Years - 50Years
All Genders
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here